IOLCPNSEIOL Chemicals and Pharmaceuticals Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 22 Aug · 17:19 IST

Submission of Voting Results along with Scrutinizer s Report with regard to the 38th Annual General Meeting of the Company

IOLCP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

IOL Chemicals and Pharmaceuticals held its 38th AGM on 22nd August 2025 via video conferencing, where all 5 resolutions were passed with overwhelming majority. Out of 127,842 shareholders on record date, 61.43% of outstanding shares participated in voting. Key resolutions included adoption of FY25 audited financial statements (99.98% in favour), re-appointment of Mr. Abhiraj Gupta as director retiring by rotation (98.32% in favour), re-appointment of Mr. Vikas Gupta as Joint Managing Director for 5 years (98.22% in favour), appointment of B.K. Gupta & Associates as Secretarial Auditor for 5 years (99.98% in favour), and ratification of Cost Auditor remuneration (99.98% in favour). The two director-related resolutions saw notable dissent from public institutional investors (around 89-95% against), though promoters fully supported all resolutions.

Likely market impact

This is a routine regulatory filing confirming that all AGM resolutions passed comfortably, signalling smooth corporate governance with no material shareholder opposition. The minor dissent on related-party director re-appointments from public institutions is typical and unlikely to affect stock price.